Literature DB >> 1846316

Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line.

F Ciardiello1, R Dono, N Kim, M G Persico, D S Salomon.   

Abstract

cripto is a gene encoding an epidermal growth factor-related protein that is expressed in undifferentiated embryonal carcinoma cells. To ascertain if cripto is capable of functioning as a transforming gene, a full-length human cripto complementary DNA under the transcriptional control of the Rous sarcoma virus long terminal repeat has been cotransfected with the selectable pSV2neo marker plasmid into immortalized mouse NOG-8 mammary epithelial cells. Several neomycin-resistant clones were isolated that express high levels of a specific cripto 4.5-kilobase mRNA transcript and possess multiple copies of cripto plasmid DNA. NOG-8 cells that express cripto are able to clone in soft agar and exhibit an approximately 3-fold increase in their anchorage-dependent growth in serum-free medium as compared to the neo-transfected NOG-8 cells. However, none of the cripto-expressing NOG-8 clones are able to form tumors in nude mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846316

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

Review 1.  Decrypting the role of Cripto in tumorigenesis.

Authors:  Michael M Shen
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 2.  Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.

Authors:  Nicholas J Kenney; Heather B Adkins; Michele Sanicola
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 3.  Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.

Authors:  Peter C Gray; Wylie Vale
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

Review 4.  Targeting the embryonic gene Cripto-1 in cancer and beyond.

Authors:  Caterina Bianco; David S Salomon
Journal:  Expert Opin Ther Pat       Date:  2010-11-13       Impact factor: 6.674

Review 5.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

6.  Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration.

Authors:  Malachia Hoover; Farhana Runa; Evan Booker; Jolene K Diedrich; Erika Duell; Blake Williams; Caroline Arellano-Garcia; Toni Uhlendorf; Sa La Kim; Wolfgang Fischer; James Moresco; Peter C Gray; Jonathan A Kelber
Journal:  Biochem Biophys Res Commun       Date:  2018-12-20       Impact factor: 3.575

7.  Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.

Authors:  Caterina Bianco; Heather B Adkins; Christian Wechselberger; Masaharu Seno; Nicola Normanno; Antonella De Luca; Youping Sun; Nadia Khan; Nicholas Kenney; Andreas Ebert; Kevin P Williams; Michele Sanicola; David S Salomon
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Cripto forms a complex with activin and type II activin receptors and can block activin signaling.

Authors:  Peter C Gray; Craig A Harrison; Wylie Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

9.  Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.

Authors:  Lian-Xin Liu; Zhi-Hua Liu; Hong-Chi Jiang; Xin Qu; Wei-Hui Zhang; Lin-Feng Wu; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.